What is the optimal medical management of ischemic heart failure?
- 30 April 2001
- journal article
- review article
- Published by Elsevier in Progress in Cardiovascular Diseases
- Vol. 43 (5) , 433-455
- https://doi.org/10.1053/pcad.2001.20670
Abstract
No abstract availableKeywords
This publication has 102 references indexed in Scilit:
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureNew England Journal of Medicine, 1996
- Twelve-Year Follow-up of Survival in the Randomized European Coronary Surgery StudyNew England Journal of Medicine, 1988
- Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart FailureNew England Journal of Medicine, 1986
- A Randomized Trial of Coronary Artery Bypass SurgeryNew England Journal of Medicine, 1985
- Thrombosis and Acute Coronary-Artery Lesions in Sudden Cardiac Ischemic DeathNew England Journal of Medicine, 1984
- Coronary artery surgery study (CASS): a randomized trial of coronary artery bypass surgery. Survival data.Circulation, 1983
- Results of coronary artery surgery in patients with poor left ventricular function (CASS).Circulation, 1983
- Effects of an Inhibitor of 3-Hydroxy-3-Methylglutaryl Coenzyme a Reductase on Serum Lipoproteins and Ubiquinone-10 Levels in Patients with Familial HypercholesterolemiaNew England Journal of Medicine, 1981
- Timolol-Induced Reduction in Mortality and Reinfarction in Patients Surviving Acute Myocardial InfarctionNew England Journal of Medicine, 1981